MARKET WIREStock Titan • 16h ago
Firefly’s headset lets users influence flight and driving simulations with brainwaves.Stock Titan report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
Why AIFF Stock dropped -2.91% Today — RQD Quant Desk Flash
$1.00 -2.91% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.99
Firefly Neuroscience Inc. (AIFF) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $15.7M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on AIFF Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is AIFF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Firefly Neuroscience Inc. (NASDAQ: AIFF) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.00 (-2.91% 1D, market cap $15.7M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, AIFF ranks #535 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does AIFF compare to CHOW and IDAI in the Technology sector?
▼
Within the Technology sector (Computer Software: Prepackaged Software), AIFF carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 56.5%, and ROIC of -35.0%. By comparison, CHOW (ChowChow Cloud International Holdings Limited) holds a D grade (48/100 RQD, P/E N/A, ROIC -35.0%, cap $15.6M) and IDAI (T Stamp Inc. (Class A)) posts a D grade (46/100 RQD, P/E N/A, ROIC -35.0%, cap $16.0M). Among the 5-stock peer group, AIFF leads on earnings multiple (N/A) while AIFF leads on capital efficiency (-35.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for AIFF?
▼
Per AIFF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000803578), Firefly Neuroscience Inc. generated $1.1M in revenue (+957.4% YoY), -$19.9M in net income, and -$8.2M in free cash flow against $10.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.99 (-0.71%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.7% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-11% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AIFF)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (34/100 Composite)
🔍 WHY AIFF SCORES 34/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (32% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (24% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 56.5% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$1.11-4.5% Next Q
42
Q2 (-2Q)Grade E$1.06-5.7% Next Q
39
Q3 (-1Q)Grade E$1.00+0% Next Q
37
CurrentGrade E$1.00-8.7% Hist 90D α
34
Trajectory: D (42) → E (34)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a AIFF Turnaround Squeeze
While AIFF currently carries a cautious 34/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Technology with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.15) and Max Pain ($1.05) forces dealer call-delta covering toward $3.31.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $AIFF• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “AIFF Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why AIFF Stock dropped -2.91% Today — RQD Quant Desk Flash
Firefly Neuroscience Inc. (AIFF) dropped -2.91% to $1.00, trading at 15% of its 52-week range ($0.62 – $3.15). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 15% of its 52-week range ($0.62 – $3.15) with RSI-14 at 43.2 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.00 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 56.5% gross margin and $0 annual free cash flow.
Live AIFF Headlines & Catalysts
MARKET WIREwww.marketscreener.com • 19h ago
Firefly Neuroscience Announces Commercial Availability of Versus Platformwww.marketscreener.com report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo Finance • 22h ago
Firefly Raises $20M Series A to Build a New Standard for SafetyYahoo Finance report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
MARKET WIREInvesting.com UK • 1d ago
Firefly Neuroscience updates brain-computer interface strategy By Investing.comInvesting.com UK report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
MARKET WIREQuiver Quantitative • 1d ago
Firefly Neuroscience Updates BCI Strategy, Highlighting Versus Platform and EEG/ERP Foundation Model InitiativeQuiver Quantitative report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo • 6d ago
Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform– Firefly’s AI foundation model, being built on more than 200,000 standardized EEG/ERP brain scans, bolsters its long-term BCI growth opportunity – – With over 3,000 Versus headsets shipped, the platform generates commer
MARKET WIREBenzinga • 7d ago
Firefly Neuroscience's Versus Platform Now Commercially Available For EEG TestingFirefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an artificial intelligence ("AI") company advancing precision neuroscience and non-invasive brain-computer interface (BCI)
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AIFF)
- ✓Walkthrough of AIFF's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
AIFF // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -53.70%🛡️ HOLDING TREND SUPPORT
2026-11-03O $1.03H $1.03L $1.00C $1.00VOL 67.4K
RES: $2.23SUP: $0.89SMA50: $1.15SMA200: $1.37
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
AIFF Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on AIFF today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for AIFF. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for AIFF today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AIFF)
Technology Rank #535 of 714
⚔️ CHOW vs AIFF Full Matrix →
1. Head-to-Head Technology Peer Comparison (AIFF vs. CHOW, IDAI, VIDA, SAGT)
Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)Across 714 tracked Technology securities in the Roarable RQD universe, Firefly Neuroscience Inc. (AIFF) ranks #535 by composite RQD confidence (34/100, grade E) and #618 by equity capitalization ($15.7M). Within this direct 5-issuer industry benchmark cohort, AIFF leads on earnings valuation at N/A trailing P/E, while AIFF leads on capital efficiency and profitability with -35.0% ROIC and 56.5% gross margin. SAGT currently holds the highest overall quantitative score in the immediate peer group at 52/100 (D+) compared with AIFF at 34/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| AIFF
ACTIVE
Firefly Neuroscience Inc. | E | 34/100 | — | 56.5% | -35.0% | -2.91% | $15.7M | Benchmark Subject |
| CHOW ChowChow Cloud International Holdings Limited | D | 48/100 | — | 12.9% | -35.0% | +106.57% | $15.6M | /chow-vs-aiff → |
| IDAI T Stamp Inc. (Class A) | D | 46/100 | — | — | -35.0% | -1.40% | $16.0M | /idai-vs-aiff → |
| VIDA VIDA Global Inc. (Class A) | D- | 41/100 | — | — | — | -7.47% | $14.4M | /vida-vs-aiff → |
| SAGT SAGTEC GLOBAL LIMITED (Class A) | D+ | 52/100 | — | — | — | -0.20% | $14.0M | /sagt-vs-aiff → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000803578In its most recent audited fiscal period (FY2025, filed 2025-12-31), Firefly Neuroscience Inc. (AIFF) reported GAAP revenue of $1.1M (+957.4% vs. FY2024 revenue of $108.0K , and +129.3% cumulative change since FY2023) , GAAP net income of -$19.9M, operating cash flow of -$8.2M, and free cash flow of -$8.2M (-33.1% YoY). On the balance sheet, AIFF closed FY2025 with $10.5M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.1M | -$19.9M | -$8.2M | -$8.2M | $10.5M | — |
| FY2024 (FY) | 2024-12-31 | $108.0K | -$10.5M | -$6.2M | -$6.2M | $4.6M | — |
| FY2023 (FY) | 2023-12-31 | $498.0K | -$2.6M | -$2.2M | -$2.2M | — | — |
3. AIFF Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs AIFF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Firefly Neuroscience Inc. (NASDAQ: AIFF) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.00 (-2.91% 1D, market cap $15.7M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, AIFF ranks #535 in composite RQD confidence.
How does AIFF compare to CHOW and IDAI in the Technology sector?
Within the Technology sector (Computer Software: Prepackaged Software), AIFF carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 56.5%, and ROIC of -35.0%. By comparison, CHOW (ChowChow Cloud International Holdings Limited) holds a D grade (48/100 RQD, P/E N/A, ROIC -35.0%, cap $15.6M) and IDAI (T Stamp Inc. (Class A)) posts a D grade (46/100 RQD, P/E N/A, ROIC -35.0%, cap $16.0M). Among the 5-stock peer group, AIFF leads on earnings multiple (N/A) while AIFF leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for AIFF?
Per AIFF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000803578), Firefly Neuroscience Inc. generated $1.1M in revenue (+957.4% YoY), -$19.9M in net income, and -$8.2M in free cash flow against $10.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is AIFF trading relative to its 50-day, 200-day, and 52-week technical levels?
AIFF last traded at $1.00 (-2.91% on volume of 67,371 shares), positioning the stock -13.04% below its 50-day simple moving average ($1.15) and -27.01% below its 200-day simple moving average ($1.37). Across its 52-week range of $0.62 to $3.15, AIFF sits at the 15.0% percentile with a 14-day RSI of 43.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $1.13).
AIFF Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is AIFF stock moving today?
Why AIFF Stock dropped -2.91% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 34/100 (E)
✓ STAGE-C NUMBER FIREWALL VERIFIED
AIFF — Firefly Neuroscience Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:50:28Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, AIFF scores 36 out of 100, a letter grade of D-, with the verdict label "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are:
- Fundamental Cash Engine: 8 / 20. The rating cites ROIC of -35% and an FCF yield of 0%. For an investor, this pillar signals that the business is not currently generating returns on capital or free cash flow to shareholders.
- Whale 13F Flow: 5 / 20. The pillar reflects institutional accumulation and options positioning. A low score indicates limited evidence of supportive institutional demand in the source data.
- Insider Conviction: 5 / 20. Per the rating, this reflects SEC Form 4 and Congressional PTR cluster flow. A low score indicates weak insider-signal support.
- Macro Regime Fit: 7 / 20. The rating cites a beta of 1.0 and sector sensitivity. The pillar suggests the stock's market sensitivity offers no offsetting defensive characteristic.
- Forensic Balance Sheet: 11 / 20. The rating cites an Altman Z-Score of 2.5, a Piotroski F-Score of 4/9, and a Debt/Equity ratio of 0.5. This is the strongest pillar, but still below midpoint.
Taken together, the investor implication is that the upside case rests on a future inflection in cash generation that the reported figures do not yet show. The valuation tradeoff is that a $16.2M market capitalization against reported operating losses leaves little margin for execution error, and the balance-sheet pillar, while the strongest, does not offset weak cash-flow and flow signals. This is an analytical reading of the rating, not a recommendation.
Business
Firefly Neuroscience Inc. (AIFF) is a NASDAQ-listed issuer in the Technology sector, operating in Computer Software: Prepackaged Software. Per the profile, the company is classified within this industry with a market capitalization of $0.0B. The source data does not describe specific products, customers, or revenue model beyond the news headlines referenced in the catalysts section.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $1.1M | $-8.9M | $-19.9M | N/A | $-8.2M | $2.7M | N/A |
| FY 2024 | $0.1M | $-10.1M | $-10.5M | N/A | $-6.2M | N/A | N/A |
| FY 2023 | $0.5M | $-3.1M | $-2.6M | N/A | $-2.2M | N/A | N/A |
Per the SEC financials, the company reported operating losses in each period shown, with a gross margin of 56.5%, an operating margin of -60%, and a net margin of -60%. ROIC is -35% per the market data. The Altman Z-Score of 2.5, Piotroski F-Score of 4/9, and Debt/Equity of 0.5 are cited within the Roarable RQD rating's forensic balance-sheet pillar. Reported cash for FY 2025 is $2.7M, while cash and debt are not available in source data for the prior periods.
Recent Catalysts & News Wire Analysis
- Versus Platform commercial availability: A MARKET WIRE item reports the commercial availability of the Versus Platform (YELLOW signal).
- Series A financing: A CATALYST item reports a $20M Series A raise to build a new standard for safety (GREEN signal).
- BCI strategy update: Multiple items reference an updated brain-computer interface strategy, including an EEG/ERP foundation model initiative (YELLOW signals).
- Headset demonstration: A MARKET WIRE item describes a headset that lets users influence flight and driving simulations with brainwaves (YELLOW signal).
Risk watch: the source data contains no quantified revenue guidance tied to these items. Per the Butterfly Supply-Chain Graph, no proprietary signals are present.
Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples
Per the Butterfly Supply-Chain Graph, the supply chain is recorded as "NONE," with no butterfly links and no proprietary signals. Upstream and downstream dependencies are not available in source data. Sector correlations are not available in source data beyond the classification of Technology / Computer Software: Prepackaged Software. An investor should watch whether commercial traction for the Versus Platform translates into reported revenue, since FY 2025 revenue of $1.1M remains small relative to the net loss of $-19.9M.
Open Questions
- What is the revenue contribution of the Versus Platform, and does it appear in reported figures?
- What are the cash and debt balances for FY 2024 and FY 2023, which are marked N/A?
- What is the runway implied by the $2.7M FY 2025 cash balance relative to the $-8.2M FCF?
- What drove the Series A raise, and what are its terms and dilution implications?
- What is the basis for the reported EPS of N/A and the absence of TTM P/E and EPS?
AIFF Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Firefly Neuroscience Inc. (AIFF) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Stock Titan • 16h ago
Firefly’s headset lets users influence flight and driving simulations with brainwaves. Stock Titan report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE www.marketscreener.com • 19h ago
Firefly Neuroscience Announces Commercial Availability of Versus Platform www.marketscreener.com report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Yahoo Finance • 22h ago
Firefly Raises $20M Series A to Build a New Standard for Safety Yahoo Finance report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Investing.com UK • 1d ago
Firefly Neuroscience updates brain-computer interface strategy By Investing.com Investing.com UK report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Quiver Quantitative • 1d ago
Firefly Neuroscience Updates BCI Strategy, Highlighting Versus Platform and EEG/ERP Foundation Model Initiative Quiver Quantitative report covering Firefly Neuroscience Inc. (AIFF) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Yahoo • 6d ago
Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform – Firefly’s AI foundation model, being built on more than 200,000 standardized EEG/ERP brain scans, bolsters its long-term BCI growth opportunity – – With over 3,000 Versus headsets shipped, the platform generates commer
🟡 MARKET WIRE Benzinga • 7d ago
Firefly Neuroscience's Versus Platform Now Commercially Available For EEG Testing Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an artificial intelligence ("AI") company advancing precision neuroscience and non-invasive brain-computer interface (BCI)
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
AIFF Bull vs. Bear Conversation Board — What's Your Call at $1.00?
🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON AIFF 🐻 67% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH
🎯 Target: $0.91 (-11.7%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is AIFF (D- • RQD 36/100) a Buy at $1.03?
Welcome to the AIFF (Firefly Neuroscience Inc.) Roar Pit. Current RQD Composite is 36/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Computer Software: Prepackaged Software. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
RE RedlineAuditor Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $0.82 (-20.4%)
Spot @ $1.03 Pump the brakes on AIFF — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on AIFF, but look at what you are paying: current EV/EBITDA multiples with 56.5% gross margins. Unless Firefly Neuroscience Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
CA CashFlowKing Verified K Arena Trader 🐂 BULLISH
🎯 Target: $1.22 (+18.4%)
Spot @ $1.03 AIFF cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on AIFF, the market is fixating on short-term headline noise in Computer Software: Prepackaged Software and ignoring the balance sheet and cash flow trajectory. At $1.03 (52-wk range $0.62 - $3.15), any beat on forward guidance forces shorts and underweight funds to chase.